Factual data · GO/NO-GO verdict · Financial model calibrated over 96 months
Taking over or creating a pharmacy in Atlanta requires a Doctor of Pharmacy degree, geographic quota compliance (1 per 2,500-3,500 inhabitants), and substantial investment (960K USD-4.2M USD USD, mostly business acquisition).
Dominant profile: business · industrielle
Atlanta (Georgia, United States) has about 506K inhabitants and shows dense business fabric (HQs, B2B services, professionals), and active industrial base (SMEs, subcontracting, family-owned mid-market). For a pharmacy project, this means a high average ticket and a setup cost above national by 20 %.
Local purchasing power and lead density allow targeting the high end of the revenue range from year 2. Concretely, initial investment calibrated for Atlanta ranges from 960K USD to 4.2M USD, and Year 1 target revenue sits between 1.8M USD and 5.4M USD — a range that already factors in the local coefficients of this city (+20% vs average on costs, +20% vs average on purchasing power).
Competitive density: high (dense supply, segmentation required).
Dominant players: regulated public-insurance sector, few private chains.
Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.
| Indicator | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Year 1 revenue | 1.8M USD → 5.4M USD | ×1,18 (ramp-up) | ×1,32 (steady-state) |
| Target net margin | negative to low | 4 % | 10 % |
| Working capital (days of revenue) | 45-60 d | 35-50 d | 30-45 d |
| Cumulative ROI | investment | ~50 % | Payback at 96 months |
These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of Atlanta, United States (cost +20% vs average, income +20% vs average).
This page combines multiple data sources for a factual analysis calibrated on Atlanta.
MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.